ResMed Inc. Declares Quarterly Dividend, Payable on September 17, 2015
Jul 30 15
The ResMed board of directors declared a quarterly dividend of $0.30 per share, an increase of 7% from the previous dividend. The dividend will have a record date of August 20, 2015, payable on September 17, 2015. The dividend will be paid in U.S. currency to holders of ResMed’s common stock trading on the New York Stock Exchange. Holders of Chess Depositary Instruments trading on the Australian Securities Exchange will receive an equivalent amount in Australian currency, based on the exchange rate on the record date, and reflecting the 10:1 ratio between CDIs and NYSE shares. The ex-dividend date will be August 18, 2015 for common stock holders and for CDI holders.
ResMed Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2015; Provides Earnings Guidance for the Full Year of 2016
Jul 30 15
ResMed Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended June 30, 2015. For the quarter, the company reported net revenue of $453,064,000 against $415,211,000 a year ago. Income from operations was $99,547,000 against $98,486,000 a year ago. Income before income taxes was $104,116,000 against $106,635,000 a year ago. Net income was $87,462,000 against $87,738,000 a year ago. Diluted earnings per share were $0.61 against $0.61 a year ago. Non-GAAP operating income (excluding the impact of SERVE-HF field safety notice expenses, donations, restructuring expenses and amortization of acquired intangible assets) was $112,686,000 against $107,220,000 a year ago. Non-GAAP net income was $96,379,000 against $93,803,000 a year ago. Non-GAAP diluted earnings per share were $0.68 against $0.66 a year ago. Cash flow from operations was $99.6 million for the quarter, reflecting strong underlying earnings and a modest increase in working capital. Capital expenditure for the quarter was $12.2 million while depreciation and amortization for the quarter totaled $17.7 million.
For the year, the company reported net revenue of $1,678,912,000 against $1,554,973,000 a year ago. Income from operations was $409,236,000 against $405,087,000 a year ago. Income before income taxes was $435,916,000 against $431,078,000 a year ago. Net income was $352,886,000 against $345,273,000 a year ago. Diluted earnings per share were $2.47 against $2.39 a year ago. Non-GAAP operating income (excluding the impact of SERVE-HF field safety notice expenses, donations, restructuring expenses and amortization of acquired intangible assets) was $428,933,000 against $421,146,000 a year ago. Non-GAAP net income was $366,754,000 against $356,901,000 a year ago. Non-GAAP diluted earnings per share were $2.57 against $2.47 a year ago. Net cash provided by operating activities was $383,180,000 against $391,268,000 a year ago. Purchases of property, plant and equipment was $62,502,000 against $72,722,000 a year ago.
For the fiscal year of 2016, the company expects gross margins to be in a range of 57% to 60%. The company expects SG&A as a percentage of revenue to be in a range of 27% to 28% for fiscal year 2016. R&D expenses is expected as a percentage of revenue to be in a range of 6% to 7% in fiscal year 2016. The effective tax rate for the full fiscal year 2016 will be in the range of 20% to 21%.